首页|Efficacy and safety of bilastine vs.levocetirizine for the treatment of chronic idiopathic urticaria:A multicenter,double-blind,double-dummy,phase Ⅲ,non-inferiority,randomized clinical trial

Efficacy and safety of bilastine vs.levocetirizine for the treatment of chronic idiopathic urticaria:A multicenter,double-blind,double-dummy,phase Ⅲ,non-inferiority,randomized clinical trial

扫码查看

Xue Chen、Xiuping Han、Bo Cheng、Hui Li、Lingling Liu、Songmei Geng、Linfeng Li、Jie Li、Qing Guo、Guoyi Zhang、Hong Fang、Jianzhong Zhang

展开 >

Department of Dermatology,Peking University People's Hospital,Beijing 100044,China

Department of Dermatology,Shengjing Hospital of China Medical University,Shenyang,Liaoning 110055,China

Department of Dermatology,The First Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian 350004,China

Department of Dermatology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China

Department of Dermatology,Peking University First Hospital,Beijing 100034,China

Department of Dermatology,The Second Affiliated Hospital of Xi'an Jiaotong University(Xibei Hospital),Xi'an,Shaanxi 710006,China

Department of Dermatology,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China

Department of Dermatology,Xiangya Hospital,Central South University,Changsha,Hunan 410008,China

Department of Dermatology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou,Guangdong 510120,China

Department of Dermatology,Hospital for Skin Diseases,Chinese Academy of Medical Sciences,Nanjing,Jiangsu 210042,China

Department of Dermatology,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou,Zhejiang 310003,China

展开 >

Menarini for sponsoring this phaseⅢ study IQVIA for providing CRO services and MedSci for medical writing services

2024

中华医学杂志(英文版)
中华医学会

中华医学杂志(英文版)

CSTPCD
影响因子:0.838
ISSN:0366-6999
年,卷(期):2024.137(12)